Clinical trial
A Phase II Trial of Ethyol (Amifostine) in Adult Patients With Advanced Myelodysplastic Syndromes
NCT00003123 is registered in ClinicalTrials.gov with Providence Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Ethyol (Amifostine) in Adult Patients With Advanced Myelodysplastic Syndromes
- Lead sponsor
- Providence Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 1997
- Completion date
- Not reported
- Enrollment
- 36 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.